We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $2.7B
1-Year Est. Return 37.16%
This Fund
S&P 500
This Quarter Est. Return
+14.69%
1 Year Est. Return
+37.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$694M
AUM Growth
+$204M
Cap. Flow
+$185M
Cap. Flow %
26.67%
Top 10 Hldgs %
58.11%
Holding
99
New
45
Increased
6
Reduced
25
Closed
22

Top Buys

Rank Stock Value
1
STUB
StubHub Holdings
STUB
+$49.4M
2
HOLX
Hologic
HOLX
+$23.2M
3
KLAR
Klarna Group
KLAR
+$17.4M
4
ROST icon
Ross Stores
ROST
+$16.4M
5
MBLY icon
Mobileye
MBLY
+$13M

Top Sells

Rank Stock Value
1
BRO icon
Brown & Brown
BRO
+$24.9M
2
QXO
QXO Inc
QXO
+$21.7M
3
SARO
StandardAero Inc
SARO
+$16.4M
4
GLXY
Galaxy Digital Inc
GLXY
+$13.9M
5
HUM icon
Humana
HUM
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 26.82%
2 Consumer Discretionary 16.69%
3 Financials 7.51%
4 Communication Services 6.55%
5 Technology 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QXO
51
QXO Inc
QXO
$14.2B
$2.13M 0.31%
112,011
-1,050,395
-90% -$21.7M
PTRN
52
Pattern Group Inc
PTRN
$3.92B
$2.01M 0.29%
+146,609
New +$2.04M
SION
53
Sionna Therapeutics
SION
$2.06B
$1.81M 0.26%
+61,457
New +$1.34M
NIQ
54
NIQ Global Intelligence PLC
NIQ
$3.17B
$1.58M 0.23%
+100,872
New +$1.76M
AHL
55
DELISTED
Aspen Insurance
AHL
$1.44M 0.21%
39,189
-229,251
-85% -$7.54M
CRBG icon
56
Corebridge Financial
CRBG
$14.1B
$1.4M 0.2%
+43,675
New +$1.49M
BROS icon
57
Dutch Bros
BROS
$8.78B
$1.31M 0.19%
+25,000
New +$1.58M
SLDE
58
Slide Insurance Holdings
SLDE
$2.32B
$1.28M 0.18%
81,119
+35,619
+78% +$584K
PYXS icon
59
Pyxis Oncology
PYXS
$165M
$1.12M 0.16%
+503,214
New +$725K
SEPN
60
Septerna Inc
SEPN
$1.49B
$1.07M 0.15%
+57,064
New +$749K
TSCO icon
61
Tractor Supply
TSCO
$16.3B
$1.03M 0.15%
+18,128
New +$1.07M
DNTH icon
62
Dianthus Therapeutics
DNTH
$5.68B
$984K 0.14%
+25,000
New +$639K
SRRK icon
63
Scholar Rock
SRRK
$5.71B
$983K 0.14%
+26,386
New +$923K
VOYG
64
Voyager Technologies
VOYG
$1.5B
$901K 0.13%
30,250
-31,250
-51% -$1.08M
KRMN
65
Karman Holdings
KRMN
$6.29B
$842K 0.12%
11,660
+2,956
+34% +$162K
TTAM
66
Titan America SA
TTAM
$3.16B
$766K 0.11%
51,304
-8,696
-14% -$128K
DLO icon
67
dLocal
DLO
$4.26B
$536K 0.08%
+37,500
New +$477K
BNTC icon
68
Benitec Biopharma
BNTC
$394M
$527K 0.08%
37,537
-14,460
-28% -$185K
ZONE
69
CleanCore Solutions
ZONE
$160M
$526K 0.08%
+260,577
New +$934K
ADT icon
70
ADT
ADT
$5.16B
$481K 0.07%
+55,242
New +$474K
ETOR
71
eToro Group
ETOR
$2.93B
$438K 0.06%
10,619
-17,166
-62% -$884K
VG
72
Venture Global Inc
VG
$35.6B
$428K 0.06%
30,163
-349,311
-92% -$4.98M
AQST icon
73
Aquestive Therapeutics
AQST
$462M
$397K 0.06%
+71,015
New +$307K
CUBI icon
74
Customers Bancorp
CUBI
$2.59B
$136K 0.02%
+2,080
New +$137K
KNTK icon
75
Kinetik
KNTK
$3.71B
$41.7K 0.01%
975
-8,506
-90% -$360K

Similar funds

Longaeva Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Longaeva Partners held 99 positions worth $694M, up 42% from $490M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Longaeva Partners deployed $185M of net new capital in Q3 2025, opening 45 new positions and adding to 6 existing holdings. Its largest new stake was StubHub Holdings: 2,695,605 shares worth $45.4M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was QXO Inc, an estimated $21.7M trimmed.

  • Longaeva Partners's largest Q3 2025 buy was StubHub Holdings: 2,695,605 shares worth $45.4M.
  • Longaeva Partners added most to Hologic in Q3 2025, an estimated $23.2M increase.
  • Longaeva Partners's biggest Q3 2025 reduction was QXO Inc, cutting an estimated $21.7M.
  • Longaeva Partners fully exited Brown & Brown in Q3 2025, selling an estimated $24.9M.
  • Longaeva Partners's ten largest holdings make up 58% of its $694M portfolio in Q3 2025.
  • Longaeva Partners opened 45 new positions and closed 22 in Q3 2025.
  • Longaeva Partners's portfolio value rose 42% quarter-over-quarter to $694M.

Based on Longaeva Partners's 13F filing for Q3 2025, filed 14 Nov 2025.